Kenya is expected to receive more than four million doses of Covid-19 vaccine in an initiative geared to ensure equitable access to Covid-19 vaccines to developing countries.
The Covax initiative, which is led by the United Nations -backed vaccine alliance Gavi, the Coalition for Epidemic Preparedness Innovations and the World Health Organisation (WHO), published it’s first distribution list for the coronavirus vaccines on Wednesday, allocating Kenya 4,176,000 doses of the AstraZeneca/Oxford vaccine.
Kenya, with a population of 48 million, will receive vaccines made by the Serum Institute of India (SII) to immunise four percent of the population or 2,088,000 people. One requires two injectable of the vaccine.
Additional doses of the vaccines will be available to the Covax facility later this year.
This story was from Standard Digital
